Phadia US recalls
Phadia US has 9 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 5 Jul 2023. 2 are still ongoing.
Total recalls9since 2012
Last 12 months0reported
Class I00% of total
Ongoing2latest 5 Jul 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 89%Class III 1 11%
Why phadia us is recalled
Product types
By year
Ongoing phadia us recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | EliA GliadinDP IgG Well in the Phadia 2500EE instrument recalled | Phadia US | Other | CA, MI, NJ |
| Device | CLASS II | Phadia 2500EE instrument -Intended recalled by Phadia US | Phadia US | Other | CA, MI, NJ |
All phadia us recalls, newest first
9 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | EliA GliadinDP IgG Well in the Phadia 2500EE instrument recalled | Phadia US | Other | CA, MI, NJ |
| Device | CLASS II | Phadia 2500EE instrument -Intended recalled by Phadia US | Phadia US | Other | CA, MI, NJ |
| Device | CLASS II | EliA dsDNA Well recalled by Phadia US | Phadia US | Other | Nationwide |
| Device | CLASS II | ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016) recalled | Phadia US | Labeling Errors | Nationwide |
| Device | CLASS II | ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01) recalled | Phadia US | Labeling Errors | Nationwide |
| Device | CLASS II | Phadia 1000 Instrument, Article Number recalled by Phadia US | Phadia US | Potency & Assay | Nationwide |
| Device | CLASS II | EliA Sample Diluent, Article number recalled by Phadia US | Phadia US | Other | 27 states |
| Device | CLASS II | Phadia 1000 Instrument (introduced as UniCAP 1000) recalled by Phadia US | Phadia US | Labeling Errors | Nationwide |
| Device | CLASS III | Phadia Varelisa Cardiolipin IgM Cardiolipin autoantibody recalled | Phadia US | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.